PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

YIN AND YANG Part 2, page-12

  1. 1,705 Posts.
    lightbulb Created with Sketch. 1856
    Yeah, this has always been a question mark for me. We are in a very unique situation here, because so much hinges on that supply agreement - which is why I was absolutely delighted by the recent upgraded agreement.

    25 years is a long time, but it is still finite. How does this play into our market valuation? Or our valuation in the eyes of a third party interested in takeover? One would think a distribution deal could be aligned with the supply agreement period, but where do we locate a template of how this plays into the valuations within such a deal? I don't think we'll know until we know, which leaves us only to speculate, and cross our fingers for an optimal outcome.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.